|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-6-30
|
|
pubmed:abstractText |
We have tried to establish short-term cultures of autologous tumors from patients with stage III and IV ovarian cancer, which could be used as active specific immunotherapy, (i.e., autologous vaccine) in such patients after debulking surgery & combination chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1084-9785
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
443-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10850331-Aged,
pubmed-meshheading:10850331-Cancer Vaccines,
pubmed-meshheading:10850331-Cell Culture Techniques,
pubmed-meshheading:10850331-Cell Division,
pubmed-meshheading:10850331-Cell Transplantation,
pubmed-meshheading:10850331-Feasibility Studies,
pubmed-meshheading:10850331-Female,
pubmed-meshheading:10850331-Humans,
pubmed-meshheading:10850331-Neoplasm Staging,
pubmed-meshheading:10850331-Ovarian Neoplasms,
pubmed-meshheading:10850331-Transplantation, Autologous,
pubmed-meshheading:10850331-Tumor Cells, Cultured
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
The feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer.
|
|
pubmed:affiliation |
Hoag Cancer Center, Newport Beach, California 92658, USA. rdillman@hoaghospital.org
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
